CTLA4 and neoplasm: For instance, studies have shown that targeting both CTLA-4 and PD-1 expands cytotoxic T cells and transforms tumor-associated monocytes and macrophages to a pro-inflammatory (M1) phenotype through increased IFN-γ secretion, producing an inflammatory tumor microenvironment (TME) [5, 19, 62].